UHPLC- Instrument Influences on Maximizing Separation Performance
This Monday afternoon session will be presided over by Jason Anspach of Phenomenex (Torrance, California), who also arranged the session with Todd Maloney of Eli Lilly and Company (Indianapolis, Indiana).
Session 510, Room 409
2:00 p.m.
This Monday afternoon session will be presided over by Jason Anspach of Phenomenex (Torrance, California), who also arranged the session with Todd Maloney of Eli Lilly and Company (Indianapolis, Indiana). This session is one of John Dolan’s recommendations and is definitely one to add to your agenda.
The session will begin with opening remarks from Anspach and continue with a presentation from Xiaoli Wang of Agilent Technologies. Wang's presentation will focus on new column technologies for better and faster separations in UHPLC.
A presentation by Kenneth Joseph Fountain of Waters Corporation will follow Wang. This presentation will discuss performance and selectivity options for HPLC and UPLC separations. Next will be the presentation from the session organizer, Jason Anspach. His talk will be about UHPLC separations without system limitation.
After a 15 minute recess, the session will pick back up with Gregory K. Webster's (Abbott Laboratories) presentation titled, "Scaling UHPLC Methods to an LC Format to Enable Method Transfer: Is this a Feasible Strategy for Pharmaceutical Analyses?"
The last presentation in this session will be given by the other session organizer, Todd Maloney. His presentation is titled: Bridging the Gap Between HPLC and UHPLC — Standardizing Column Geometry and Simplifying Method Development Strategies for Pharmaceutical Analysis. The session will conclude with a brief group discussion and question/answer period.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
